Who
Federica F. O'Brien
Director
Company insider
Files Form 4 as: Director, MacroGenics; Director, TELA Bio.
In numbers
- Trades disclosed
- 33
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 4 Jun 2020
- Last trade
- 19 May 2026
- Last filed
- 20 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 May 2026filed 20 May 2026 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 19 May 2026filed 20 May 2026 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 19 May 2026filed 20 May 2026 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,750 at $0.00 | filing |
| 19 May 2026filed 20 May 2026 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,750 at $0.00 | filing |
| 18 May 2026filed 20 May 2026 | MGNX MacroGenicsBiotechnology | SEC FORM 4 Code M | —3,750 | filing |
| 18 May 2026filed 20 May 2026 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,750 at $0.00 | filing |
| 18 May 2026filed 20 May 2026 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,750 at $0.00 | filing |
| 18 May 2026filed 20 May 2026 | MGNX MacroGenicsBiotechnology | SEC FORM 4 Code M | —3,750 | filing |
| 28 May 2025filed 30 May 2025 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —11,700 at $0.00 | filing |
| 28 May 2025filed 30 May 2025 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —7,950 at $0.00 | filing |
| 21 May 2025filed 22 May 2025 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,750 at $0.00 | filing |
| 21 May 2025filed 22 May 2025 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 21 May 2025filed 22 May 2025 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | $83K64,961 at $1.27 | filing |
| 20 May 2025filed 22 May 2025 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,500 at $0.00 | filing |
| 20 May 2025filed 22 May 2025 | MGNX MacroGenicsBiotechnology | SEC FORM 4 Code M | —6,500 | filing |
| 4 Jun 2024filed 6 Jun 2024 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —6,200 at $0.00 | filing |
| 4 Jun 2024filed 6 Jun 2024 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —4,250 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,500 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,500 at $0.00 | filing |
| 20 May 2024filed 22 May 2024 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.